What is Sheel Biotech Ltd (SHEEL) share price return in the past 10 years?

Data is not available for this company

What is the share price of Sheel Biotech Ltd (SHEEL)?

Company share prices are keep on changing according to the market conditions. The current trading price of Sheel Biotech Ltd (SHEEL) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Sheel Biotech?

The latest standalone P/E ratio of Sheel Biotech as of 01-Jan-1970 is 8.93.

What is the P/B ratio of Sheel Biotech Ltd (SHEEL)?

The latest standalone P/B ratio of Sheel Biotech Ltd (SHEEL) as of 01-Jan-1970 is 0.81.

What is the 52-week high and low of Sheel Biotech Ltd (SHEEL)?

The 52-week high of Sheel Biotech Ltd (SHEEL) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Sheel Biotech Ltd (SHEEL) Share Analysis – Quality, Growth & Valuation Zone & DeciZen Rating

Name: Sheel Biotech Ltd (SHEEL)
Brand: Sheel Biotech

Key Metrics

Market Cap

₹95 Cr.

P/E Ratio

8.93

Price to Book (P/B)

0.81

Price to Sales (P/S)

0.93

EV/EBITDA

7.22

Return on Capital Employed (ROCE)

14.78%

Current Price

₹0

Return on Equity (ROE)

13.59%

Return on Assets (ROA)

9.71%

Operating Profit Margin

14.7%

Net Profit Margin

10.45%

Gross Profit Margin

13.5%

Book Value per Share

₹57.9

Sales Growth (YoY)

10.26%

Sales Growth (3 Years)

12.88%

Operating Profit Growth (1 Year)

3.6%

Operating Profit Growth (3 Years)

32.88%

Net Profit Growth (1 Year)

1.62%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

33.11%

Dividend Yield

0.00%

Promoter Holding

72.29%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Stock return of Sheel Biotech Ltd over the last decade?

Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

Q.1 Revenue growth of Sheel Biotech Ltd?

Sheel Biotech Ltd revenue growth is 10.3% for FY-2025, which is below its 5-year CAGR of 10.79%, indicating slower growth.

Q.1 Which industry/sub-sector does Sheel Biotech Ltd belong to?

Sheel Biotech Ltd belongs to the Agriculture & Allied activities sector, operating specifically within the Agriculture segment.

Q.1 Promoter shareholding and pledge status of Sheel Biotech Ltd?

Promoters hold 72.29% of the Sheel Biotech Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Sheel Biotech Ltd vs industry peers?

Sheel Biotech Ltd revenue CAGR is 10.79%, compared to the industry median CAGR of 5.31%, indicating faster growth and gaining its market share.

DeciZen - make an informed investing decision on Sheel Biotech

Based on:

Data

M-Cap below 100cr DeciZen not available

Sheel Biotech stock performance

Key Ratios

Is Sheel Biotech Ltd an attractive stock to invest in?

1. Is Sheel Biotech Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Sheel Biotech Ltd is a average quality company.

2. Is Sheel Biotech Ltd undervalued or overvalued?

The key valuation ratios of Sheel Biotech Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Sheel Biotech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sheel Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	17.1%	15.8%	13.4%	13%	9.1%	8.1%	7.2%	9.5%	15.4%	14.8%	-
Value Creation Index ⓘ	0.2	0.1	-0.1	-0.1	-0.4	-0.4	-0.5	-0.3	0.1	0.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	70.1	70.6	60.5	60.8	61	63	70.7	80.1	92.3	102	102
Sales YoY Gr.	-	0.7%	-14.3%	0.5%	0.3%	3.4%	12.2%	13.3%	15.2%	10.3%	-
Adj EPS ⓘ	3.8	3.8	3.7	4.4	3.1	3.3	3.1	3.5	7.2	7	5.2
YoY Gr.	-	-1.1%	-1.9%	19.1%	-31%	6.9%	-4.9%	12.6%	105.4%	-3.1%	-
BVPS (₹) ⓘ	24.1	27.2	30.2	34	36.3	39.1	41.2	43.8	50.1	56.1	57.9
Adj Net Profit ⓘ	5.5	5.5	5.4	6.4	4.4	4.7	4.5	5.1	10.4	10.4	11
Cash Flow from Ops. ⓘ	2	4.2	-0.8	0.5	-0.3	0	2.2	9.3	-0.9	9.2	-
Debt/CF from Ops. ⓘ	5.1	2.1	-15.4	28.5	-56	0	10.8	2.1	-25.6	1.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	4.2%	10.8%	12.9%	10.3%
Adj EPS ⓘ	6.9%	17.9%	30.9%	-3.1%
BVPSⓘ	9.8%	9.1%	10.8%	11.9%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	17	14.7	12.9	13.8	8.7	8.6	7.7	8.2	15.3	13.3	9.2
Op. Profit Mgn % ⓘ	11.5	11.2	12.3	13.5	10.9	10.3	9	11	15.7	14.7	NAN
Net Profit Mgn % ⓘ	7.9	7.8	8.9	10.6	7.3	7.5	6.4	6.3	11.3	10.2	10.5
Debt to Equity ⓘ	0.3	0.2	0.3	0.3	0.3	0.4	0.4	0.3	0.3	0.2	-
Working Cap Days ⓘ	247	284	336	346	406	427	409	385	360	362	0
Cash Conv. Cycle ⓘ	175	220	279	295	323	342	338	305	301	314	0

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 12.88%

Net Profit is growing at healthy rate in last 3 years 30.88%

Return on Equity has declined versus last 3 years average to 9.20%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	5.2	-
TTM Sales (₹ Cr.)	102	-
BVPS (₹) ⓘ	57.9	-
Reserves (₹ Cr.) ⓘ	98	-
P/BV ⓘ	0.81	-
PE ⓘ	8.93	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	94.9
Equity (₹ Cr.)	20.4
Face Value (₹)	10
Industry PE ⓘ	19.2

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Sheel Biotech - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	70.09	70.59	60.47	60.76	60.95	63.03	70.74	80.12	92.28	101.75
Operating Expenses ⓘ +	62.04	62.66	53.03	52.53	54.34	56.53	64.35	71.29	77.83	86.78
Manufacturing Costs	1	0.98	0.71	0.93	0	11.58	0.92	1.44	1.67	1.23
Material Costs	50.25	50.16	39.37	37.66	37.72	31.42	47.17	53.06	56.95	65.07
Employee Cost	6.02	6.06	6.95	7.64	8.53	7.81	9.09	9.22	11.19	12.22
Other Costs ⓘ	4.77	5.45	5.99	6.30	8.08	5.72	7.18	7.57	8.02	8.26
Operating Profit ⓘ	8.05	7.94	7.43	8.23	6.61	6.50	6.38	8.83	14.45	14.97
Operating Profit Margin (%)	11.5%	11.2%	12.3%	13.5%	10.8%	10.3%	9.0%	11.0%	15.7%	14.7%
Other Income ⓘ +	0.12	0.11	0.13	0.08	0.18	0.22	0.33	0.08	0.26	0.52
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	1.26	1.41	1.17	1.25	1.58	1.17	1.18	1.52	1.48	1.77
Depreciation ⓘ	0.89	0.67	0.64	0.63	0.75	0.76	0.94	1.02	0.99	0.90
Profit Before Tax ⓘ	6.02	5.97	5.75	6.43	4.46	4.80	4.59	6.37	12.25	12.82
Tax ⓘ	0.45	0.49	0.37	0.01	0.04	0	0.08	1.29	1.78	2.19
Profit After Tax	5.56	5.48	5.38	6.42	4.42	4.80	4.51	5.08	10.47	10.64
PAT Margin (%)	7.9%	7.8%	8.9%	10.6%	7.3%	7.6%	6.4%	6.3%	11.4%	10.5%
Adjusted EPS (₹)	3.8	3.8	3.7	4.4	3.1	3.3	3.1	3.5	7.2	7.1
Dividend Payout Ratio (%)	14.90%	15.10%	15.40%	12.90%	18.80%	16%	28.50%	25.30%	12.30%	14.10%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	34.97	39.45	43.84	49.26	52.68	56.71	59.75	63.54	72.69	83.85
Share Capital ⓘ	4.14	4.14	4.14	4.14	4.14	4.14	4.14	4.14	4.14	14.95
Reserves ⓘ	30.82	35.31	39.69	45.12	48.54	52.57	55.61	59.40	68.55	68.90
Debt +	10.02	8.43	11.53	13.53	17.24	20.88	22.54	17.30	23.28	17.17
Long Term Debt	0.86	0.06	0.51	3.53	7.76	12.12	13.38	9.44	10.27	4.82
Short Term Debt	9.17	8.36	11.02	10	9.48	8.76	9.15	7.86	13.01	12.34
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	6.12	7.56	2.86	5.08	7.71	3.41	8.34	8.20	4.59	4.14
Others Liabilities ⓘ	8.33	11.21	2.36	2.47	3.75	1.35	2.46	4.85	5.28	8.07
Total Liabilities ⓘ	59.44	66.64	60.58	70.34	81.39	82.34	93.08	93.89	105.84	113.23
Fixed Assets
Net Fixed Assets ⓘ +	8.02	7.80	7.82	7.66	8.07	7.55	7.65	7.93	7.24	7.49
Gross Block	14.82	7.80	15.79	16.26	8.07	7.55	18.57	19.87	20.16	21.27
Accumulated Depreciation	6.80	0	7.97	8.60	0	0	10.92	11.94	12.93	13.78
CWIP ⓘ	0	0	0	0	0	0	0.14	0	0	0
Investments ⓘ	0.01	0.01	0.01	0.01	0.01	0.01	0.80	0.80	0.80	0.79
Inventories	8.80	4.36	5.06	5.09	8.48	6.28	11.83	19.30	32.77	39.39
Trade Receivables	37.99	51.27	44.26	53.45	56.40	60.69	64.71	56.05	57.70	55.08
Cash Equivalents	0.20	0.22	0.10	0.11	0.22	0.46	0.31	0.21	0.60	0.46
Others Assets ⓘ	4.43	2.98	3.33	4.03	8.19	7.37	7.65	9.61	6.72	10.03
Total Assets ⓘ	59.44	66.64	60.58	70.34	81.39	82.34	93.08	93.89	105.84	113.23

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	2.03	4.19	-0.75	0.48	-0.31	2.19	9.29	-0.92	9.21
PBT ⓘ	6.02	5.97	5.75	6.43	4.46	4.59	6.37	12.25	12.82
Adjustment ⓘ	2.27	1.95	1.93	1.88	1.97	2.05	2.53	2.48	2.18
Changes in Working Capital ⓘ	-5.8	-3.25	-8.07	-7.83	-6.7	-4.27	0.4	-14.33	-3.8
Tax Paid ⓘ	-0.45	-0.49	-0.36	0	-0.04	-0.18	-0	-1.32	-1.99
Cash Flow From Investing Activity ⓘ +	-0.52	-0.40	-0.59	-0.42	-1.08	-2.12	-2.18	-0.25	-2.25
Capex	-0.59	-0.45	-0.66	-0.48	-1.16	-1.16	-1.15	-0.29	-1.04
Net Investments	0	0	0	0	0	-0.79	0	0	0.20
Others ⓘ	0.07	0.05	0.07	0.05	0.08	-0.17	-1.02	0.04	-1.41
Cash Flow From Financing Activity ⓘ +	-1.41	-3.76	1.22	-0.05	1.51	-0.23	-7.22	1.56	-7.10
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	2.02
Net Proceeds from Borrowing ⓘ	-0.69	-0.82	0.45	3.02	4.22	1.84	-3.94	0.83	-5.45
Interest Paid ⓘ	-1.13	-1.14	-0.89	-1.04	-1.20	-1.18	-1.52	-1.48	-1.45
Dividend Paid ⓘ	-0.83	-0.83	-0.83	-0.83	-0.83	-1.28	-1.28	-1.33	-1.50
Others ⓘ	1.24	-0.97	2.49	-1.21	-0.69	0.40	-0.47	3.54	-0.73
Net Cash Flow ⓘ	0.10	0.03	-0.12	0	0.12	-0.15	-0.10	0.39	-0.14

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	17.02	14.73	12.93	13.8	8.67	8.77	7.75	8.23	15.38	13.59
ROCE (%)	17.14	15.81	13.37	12.98	9.07	8.05	7.16	9.5	15.35	14.78
Asset Turnover Ratio	1.26	1.12	0.95	0.93	0.8	0.77	0.81	0.86	0.92	0.93
PAT to CFO Conversion(x)	0.37	0.76	-0.14	0.07	-0.07	0	0.49	1.83	-0.09	0.87
Working Capital Days
Receivable Days	179.60	230.80	288.40	293.50	329	339	323.50	275.10	225	202.30
Inventory Days	46.60	34	28.40	30.50	40.60	42.70	46.70	70.90	103	129.40
Payable Days	60.50	49.80	48.30	38.50	61.90	64.60	45.50	56.90	41	24.50

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sheel Biotech Ltd FAQs

The current trading price of Sheel Biotech on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Sheel Biotech stood at ₹94.94 Cr

The latest P/E ratio of Sheel Biotech as of 31-Dec-1969 is 8.93.

The latest P/B ratio of Sheel Biotech as of 31-Dec-1969 is 0.81.

The 52-week high of Sheel Biotech is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sheel Biotech is ₹102 ( Cr.) .

About Sheel Biotech Ltd

Sheel Biotech was incorporated as a private limited company with the name of “Sheel Biotech Private Limited” under the Companies Act, 1956 vide certificate of incorporation dated November 26, 1991, issued by that time Registrar of Companies, Delhi & Haryana. Further, the name of the company changed from “Sheel Biotech Private Limited” to “Sheel Biotech Limited” on April 02, 1992.

The company is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintains greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). Additionally, it delivers green landscaping services to both government and private sectors. It is an ISO 9001:2015, ISO 14001:2015 & ISO 45001:2018 certified company and is managed by industry experts and professionals with knowledge in the field of Biotechnology, Agriculture, Floriculture, Horticulture, Tissue Culture and Green Houses. The company is based in Delhi and has presence across India.

Business area of the company

Business Segments

Tissue Culture Segment: Tissue culture technology is fundamentally based on the theory of totipotency, which refers to the ability of a single cell to develop into an entire plant. This technique is used to grow cells, tissues, or organs in a controlled, sterile environment outside their natural habitat. In this segment it produces and supply plants to the public as well as to the government. It has developed an equipped lab using Dutch Technology in Manesar supported with scientists and agricultural professionals.

Organic Farming Segment: Since 2009, the company has been working in organic farming across 15 states in India, managing projects under various government schemes like NHM, PKVY, and BPKP. It helps with organic certification through both NPOP and PGS India. Its work involves applying for tenders, becoming a government-approved service provider, and implementing policies to boost horticultural growth, increase crop production, ensure quality planting materials, promote organic practices, and provide calamity relief.

Planting and Landscaping: The company offers a comprehensive suite of services through its prestigious Planting and Landscaping division. Specializing in the creation of stunning and functional outdoor spaces, it covers every aspect of landscaping, from concept to completion.

Farmer Producer Organization (FPO): A FPO in India is a collective of farmers who come together to pool their resources for the purpose of improving their agricultural production, marketing, and overall economic viability. The concept of FPO is based on the theory of economies of scale and aimed at promoting collective approaches by institutionalizing business efforts of farming community. The company is promoting 50 FPOs across different geographies in India.

Green & Packhouse Segment: Greenhouse and packhouse farming involve controlled environments and post-harvest handling to optimize crop production and quality. It manufactures and maintains of Green House/ Shade House & Hydrphonics since 2006. In last more than a decade the company has worked on various projects. Few of them were for farmers, governments, co-operative societies, corporates etc.

Key events and Milestones

1991: Incorporation of Company.
1992: Conversion from Private Company to Public Company.
1994: Opening of Tissue Culture Lab in Manesar, Haryana.
2006: Entered in the Green Houses Segment.
2008: Entered in the Organic Segment.
2012: Establishment of the tissue culture in country Eritrea (East Africa).
2016: Establishment of New Production facility at Pilkhua, Uttar Pradesh.
2017: Entered in the Packhouse segment.
2018: Entered in Landscaping and Planting Segment and got an order for landscaping in the smart cities.
2020: Development of New line in plants developed by cutting through Dutch Technology.
2021: Empaneled as CBBO for the Visionary scheme of FPO of Govt of India.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Sheel Biotech Ltd (SHEEL) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating